Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Delon

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Marseille Medical|January 1, 1971
[A case of mesothelioma with multiple localizations]R Morell, O Bardaji, J Delon, et al.
Autoimmunity Reviews|December 7, 2024
Current landscape of monogenic autoinflammatory actinopathies: A literature reviewP Mertz, V Hentgen, G Boursier, et al.
Revue De Tuberculose Et De Pneumologie|June 1, 1972
[Course of nasal secretion IGA levels under the effect of local antibacterial vaccination. Measurement of the antistreptoccal activity of these secretions]F B Michel, A Serre, M Gassin, et al.
La Revue De Medecine Interne|August 18, 2023
[Monogenic auto-inflammatory diseases associated with actinopathies: A review of the literature]P Mertz, V Hentgen, G Boursier, et al.
Marseille Medical|January 1, 1972
[Cytopathological study of the sputum in cases of pulmonary cancer-tuberculosis association]R Morell, O Bardaji, J Delon, et al.
European Journal of Immunology|February 5, 1999
Chronic intravenous injections of antigen induce and maintain tolerance in T cell receptor-transgenic miceN Bercovici, J Delon, C Cambouris, et al.
European Journal of Immunology|December 1, 1996
The CD8 beta polypeptide is required for the recognition of an altered peptide ligand as an agonistV Renard, J Delon, I F Luescher, et al.
Immunity|June 10, 1998
Modifications of CD8+ T cell function during in vivo memory or tolerance inductionC Tanchot, S Guillaume, J Delon, et al.
Immunity|November 7, 1998
CD8 expression allows T cell signaling by monomeric peptide-MHC complexesJ Delon, C Grégoire, B Malissen, et al.
The Journal of Biological Chemistry|April 4, 1997
Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifsM Bléry, J Delon, A Trautmann, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Marseille Medical|January 1, 1971
[A case of mesothelioma with multiple localizations]R Morell, O Bardaji, J Delon, et al.
Autoimmunity Reviews|December 7, 2024
Current landscape of monogenic autoinflammatory actinopathies: A literature reviewP Mertz, V Hentgen, G Boursier, et al.
Revue De Tuberculose Et De Pneumologie|June 1, 1972
[Course of nasal secretion IGA levels under the effect of local antibacterial vaccination. Measurement of the antistreptoccal activity of these secretions]F B Michel, A Serre, M Gassin, et al.
La Revue De Medecine Interne|August 18, 2023
[Monogenic auto-inflammatory diseases associated with actinopathies: A review of the literature]P Mertz, V Hentgen, G Boursier, et al.
Marseille Medical|January 1, 1972
[Cytopathological study of the sputum in cases of pulmonary cancer-tuberculosis association]R Morell, O Bardaji, J Delon, et al.
European Journal of Immunology|February 5, 1999
Chronic intravenous injections of antigen induce and maintain tolerance in T cell receptor-transgenic miceN Bercovici, J Delon, C Cambouris, et al.
European Journal of Immunology|December 1, 1996
The CD8 beta polypeptide is required for the recognition of an altered peptide ligand as an agonistV Renard, J Delon, I F Luescher, et al.
Immunity|June 10, 1998
Modifications of CD8+ T cell function during in vivo memory or tolerance inductionC Tanchot, S Guillaume, J Delon, et al.
Immunity|November 7, 1998
CD8 expression allows T cell signaling by monomeric peptide-MHC complexesJ Delon, C Grégoire, B Malissen, et al.
The Journal of Biological Chemistry|April 4, 1997
Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifsM Bléry, J Delon, A Trautmann, et al.
Pageof 3